About the ASAP Collaborative Research Network (CRN)
The Collaborative Research Network (CRN) is the first of its kind to foster an environment that facilitates the rapid and free exchange of scientific ideas to spark new discoveries for Parkinson’s disease (PD). Our program utilizes open science principles to improve outcomes, foster collaboration, generate resources, and share data assets for accelerating the pace of discovery within a global research network.
Our Approach Centers On:
Encouraging diverse perspectives and open discourse to support high-risk, ambitious projects, reshaping how science in the Parkinson’s field is conducted.
Reinvigorating the research pipeline to identify new targets and pathways for translational studies and commercialization.
multidisciplinary, international teams
investigators
countries
institutions
An ASAP Program
A Program of ASAP
The CRN is a program of the Aligning Science Across Parkinson’s initiative. ASAP is managed by the Coalition for Aligning Science (CAS) and works collaboratively with The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to implement its programs, including the CRN.
We operate through a centralized model that includes program management, scientific coordination, and community engagement – all designed to streamline operations, ensure compliance with open science principles, and enable seamless collaboration across its international network of investigators.
Explore the CRN
Explore the CRN
We are structured around the principles of collaboration, creativity, flexibility, and transparency, bringing together multidisciplinary teams to tackle high-priority PD research questions through shared goals and open science. Through our open science policy, the network ensures that discoveries are rapidly disseminated and broadly accessible to the scientific community.
Explore the Research Community →
Learn About Impact →
More Highlights
Learn more about how our research network is making strides in the Parkinson’s research community.
ASAP Research Round-Up | Q1 2026
Review Q1 2026 highlights from across ASAP's portfolio, showcasing efforts to advance Parkinson’s discovery, facilitate the rapid global exchange of ideas, broaden open-science accessibility, and support the next generation of Parkinson’s researchers.
GP2 Visits Nigeria: Commissioning of Nigeria’s First Molecular Laboratory for Parkinson’s Disease Genetics
Located within the Kesington Adebukunola Adebutu Research Centre (KAARC), the GP2-College of Medicine University of Lagos (CMUL) Molecular Laboratory for Parkinson’s Disease Research's goal is to extract and analyze DNA from Nigerian patients on-site, ensuring that West African ancestry genetic sequences are no longer underrepresented but are instead a driving contributor to global research.
Listen: Building a Global Genetic Map of Parkinson’s with Andy Singleton and Ignacio Mata
Listen as Andy Singleton, co-lead of the Global Parkinson's Genetics Program (GP2), and Nacho Mata, Cleveland Clinic geneticist and LARGE-PD founder, discuss how GP2 is accelerating discovery and expanding global representation in Parkinson’s research.